Want to join the conversation?
$BXLT and $MNTA announced that M923, a proposed HUMIRA (adalimumab) biosimilar, met the primary endpoint in a randomized, double-blind, three-arm, parallel group, single-dose study. HUMIRA is a significant intervention for patients with autoimmune/inflammatory diseases.
$GOOG’s Waymo accuses Uber of stealing its intellectual property. Startup Otto, which was recently acquired by Uber, also named in the lawsuit. Stage set for another dramatic legal battle!
We all knew $VALE CEO Murilo Ferreira was going out soon, but now I hear he has no idea who will succeed him!
$JCP, another traditional retailer that just shocked us with its biggest number of store closures.